Shann Jiang - Aug 2, 2021 Form 3 Insider Report for ABVC BIOPHARMA, INC. (ABVC)

Role: CSO and Director, Director
Signature: /s/ Tsang-Shann Jiang
Stock symbol: ABVC
Transactions as of: Aug 2, 2021
Transactions value $: $0
Form type: 3
Date filed: 11/15/2021, 04:17 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ABVC	Common Stock						12.1M	Aug 2, 2021	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Dr. Tsung-Shann Jiang holds 8,296,968 shares of common stock through his ownership in YuanGene Corporation, 11,603 shares of the Company's common stock through BioLite, 19,609 shares through Rgene Corporation, 143,264 shares through BioFirst, 674,723 shares through Lion Arts, 509,877 shares through LionGene, 8,850 shares through Genepro Investment, 213,120 shares through Keypoint, 64,215 shares through Shu-Ling Chiang, and the rest of 2,161,742 shares through direct ownership. YuanGene Corporation is a company wholly-owned by Lion Arts, which is owned by Shu-Ling Chiang (80%) and Dr. Tsung-Shann Jiang (20%); however, YuanGene appointed Eugene Jiang to have sole voting control over the shares held by YuanGene.

Content

Dr. Tsung-Shann Jiang holds 8,296,968 shares of common stock through his ownership in YuanGene Corporation, 11,603 shares of the Company's common stock through BioLite, 19,609 shares through Rgene Corporation, 143,264 shares through BioFirst, 674,723 shares through Lion Arts, 509,877 shares through LionGene, 8,850 shares through Genepro Investment, 213,120 shares through Keypoint, 64,215 shares through Shu-Ling Chiang, and the rest of 2,161,742 shares through direct ownership. YuanGene Corporation is a company wholly-owned by Lion Arts, which is owned by Shu-Ling Chiang (80%) and Dr. Tsung-Shann Jiang (20%); however, YuanGene appointed Eugene Jiang to have sole voting control over the shares held by YuanGene.